References

Citations

1. Morgan K (2003). Daytime activity and risk factors for late-life insomnia. Journal of Sleep Research, 12(3): 231–238.

2. Smith MT, et al. (2002). Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. American Journal of Psychiatry, 159(1): 5–11.

3. Littner M, et al. (2003). Practice parameters for using polysomnography to evaluate insomnia: An update. Sleep, 26(6): 754–760.

4. Edinger JD, et al. (2001). Cognitive behavioral therapy for treatment of chronic primary insomnia: A randomized controlled trial. JAMA, 285(14): 1856–1864.

5. Holbrook AM, et al. (2000). The diagnosis and management of insomnia in clinical practice: A practical evidence-based approach. Canadian Medican Association Journal, 162(2): 216–220.

6. Estivill E, et al. (2003). Consensus on drug treatment, definition, and diagnosis for insomnia. Clinical Drug Investigations, 23(6): 351–385.

7. Hadley S, Petry J (2003). Valerian. American Family Physician, 67(8): 1755–1758.

Other Works Consulted

• Holbrook AM, et al. (2000). Meta-analysis of benzodiazepine use in the treatment of insomnia. Canadian Medical Association Journal, 162(2): 225–233.

• Chesson A Jr, et al. (2000). Practice parameters for the evaluation of chronic insomnia. Sleep, 22(8): 1128–1133.

• Lippmann S, et al. (2001). Insomnia: Therapeutic approach. Southern Medical Journal, 94(9): 866–893.

• Ropper AH, Brown RH (2005). Sleep and its abnormalities. In Adams and Victor's Principles of Neurology, 8th ed., pp. 333–351. New York: McGraw-Hill.